Corrigendum to “Highly versus less bioavailable oral antibiotics in the treatment of gram-negative bloodstream infections: a propensity-matched cohort analysis” [Clin Microbiol Infect 29(4) (2023 April) 490-497]

The authors regret that the p-values in Table 4 were mis-transcribed. We can confirm that the odds ratios and 95% confidence intervals are correct in table 4, but the p-values are incorrect. This error occurred when adding the post-hoc analysis in the final revision. The correct p-values in table 4 should be.•30d Composite outcome: p=0.027•30 day mortality: p=0.048•30 day recurrent BSI: p=0.0063•30 day re-admission: p=0.20 The authors would like to apologise for any inconvenience caused. Highly versus less bioavailable oral antibiotics in the treatment of gram-negative bloodstream infections: a propensity-matched cohort analysisClinical Microbiology and InfectionVol. 29Issue 4PreviewIn this study, we evaluated the clinical outcomes associated with the use of highly bioavailable oral antibiotics (fluoroquinolones and trimethoprim-sulfamethoxazole) compared with the less-bioavailable oral antibiotics (β-lactams) in gram-negative bloodstream infections (BSIs). Full-Text PDF